You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.

3 Biotech Stocks to Buy for the “Golden Age of Medicine”

A year ago, medical experts and Nobel Laureates interviewed by The New York Times proclaimed “a Golden Age of Medicine” is here.

And in the 12 months since, a flurry of new drug and medical discoveries has proven them to be right.

From new cancer treatment breakthroughs, to the first-ever FDA-approved genetic editing treatment for illness, new medical advances are helping to cure millions of people from diseases that used to stump scientists.

And in the process, the “Golden Age of Medicine” has lit a fire under three pioneering biotech stocks.

27% profit every 20 days?

This is what I’m averaging with my option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. I have an 83% win rate.

Here’s how I do it.